Bay Street News, August 10th, 2020

BRISBANE, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK) today announced that the company will present 38-week […]

Three Cohorts Enrolled in Phase 1/2 pheNIX Gene Therapy Trial for PKUProgressed Into Later Stages of IND-Enabling Studies for MLD […]

Net sales increased 14%Gross Margin increased 350 basis pointsMaintains fiscal 2020 outlookNORWALK, Conn., Aug. 10, 2020 (GLOBE NEWSWIRE) — Reed’s […]

– ENHANCE-IT study of MAT9001 against Vascepa® expected to be fully enrolled in August 2020; topline data anticipated Q1 2021 […]

BERKELEY HEIGHTS, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) — CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing […]

— Continued robust treatment response from both high and low doses —— Long-term durability beyond 15 months from single IVT […]

NASHVILLE, Tenn., Aug. 10, 2020 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) today reported results for the second quarter […]

AUSTIN, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading […]

SANTA CLARA, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the largest online talent solution, as measured […]

Announced agreement for strategic combination with F-star Therapeutics to advance a pipeline of multiple clinical-stage immuno-oncology programsContinued to advance IV […]